General Information of the Compound
Compound ID
CP0434335
Compound Name
4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole
    Show/Hide
Synonyms
4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole
CHEMBL239895
SCHEMBL17969081
    Show/Hide
Structure
Formula
C12H12N4
Molecular Weight
212.256
Canonical SMILES
CC(C)c1ccc(cc1)-c1nn[nH]c1C#N
    Show/Hide
InChI
InChI=1S/C12H12N4/c1-8(2)9-3-5-10(6-4-9)12-11(7-13)14-16-15-12/h3-6,8H,1-2H3,(H,14,15,16)
    Show/Hide
InChIKey
WEMPWGDVLUDOBY-UHFFFAOYSA-N
Physicochemical Property
logP
2.46678
Rotatable Bonds
2
Heavy Atom Count
16
Polar Areas
65.36
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44437844
ChEMBL ID
CHEMBL239895
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000284 MDA-MB-453 Homo sapiens (Human)  1
1
IC50 = 13500 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole )
Drug Name 4-(4-isopropylphenyl)-5-cyano-2H-1,2,3-triazole
Target(s)
ERBB2 messenger RNA (HER2 mRNA)
Inhibitor